Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06428175 · ClinicalTrials.gov registry record · NA

Hospital-to-Home Transitional Care Interventions (H2H-TCI) Children/Youth With Special Health Care Needs (CYSHCN)

A NA study of Pediatrics and Health Care, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
480
Enrollment target
2
Study locations

NCT06428175: Recruiting NA study of Pediatrics and Health Care, sponsored by Duke University.

NCT06428175 is a NA study of Pediatrics and Health Care that is actively recruiting participants, run by Duke University. The registered enrollment target is 480 participants, below the 1,310-participant average among 15 other Pediatrics trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06428175, a NA study of Pediatrics and Health Care, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
480 participants
Enrollment target
2
Study locations

Study Summary

Aim 1: Compare the effectiveness of focused dose vs extended dose hospital-to-home Transitional Care Interventions (H2H-TCI) on health service use and parent-reported confidence for hospitalized CYSHCN. Aim 2: Compare the effectiveness of focused and extended dose H2H-TCI among vulnerable CYSHCN subgroups. Hypothesis: Both H2H-TCI arms will improve primary outcomes more for CYSHCN with higher versus lower clinical complexity; while extended H2H-TCI will better mitigate racial/ethnic outcome disparities than focused H2H-TCI. Aim 3: Evaluate implementation context, processes, and mechanisms via a multi-phase mixed methods study design.

Primary Outcome

30-day, all-cause composite readmission and emergency department (ED) visit rate

Interventions

  • BEHAVIORAL Focused Dose Hospital-to-Home Transitional Care Interventions
  • BEHAVIORAL Extended Dose Hospital-to-Home Transitional Care Interventions

Study Locations (2)

North Carolina

  • UNC Hospitals - Chapel Hill
  • DUHS - Durham

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2025-08-28
Est. Completion 2029-02
Phase NA
Duke University

1,725 total trials

What NCT06428175 shows while recruiting

NCT06428175 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,310-participant average among 15 other Pediatrics trials with a reported enrollment target (63% lower).

The record links to 5 conditions, with Pediatrics appearing as the primary indexed condition, and to 2 interventions - of which Focused Dose Hospital-to-Home Transitional Care Interventions is the first listed.

NCT06428175 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06428175 about?

NCT06428175 is a clinical study titled "Hospital-to-Home Transitional Care Interventions (H2H-TCI) Children/Youth With Special Health Care Needs (CYSHCN)". Aim 1: Compare the effectiveness of focused dose vs extended dose hospital-to-home Transitional Care Interventions (H2H-TCI) on health service use and parent-reported confidence for hospitalized CYSHCN. Aim 2: Compare the effectiveness of focused and extended dose H2H-TCI among vulnerable CYSHCN sub...

What is the current status of trial NCT06428175?

This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2025-08-28. Estimated completion is 2029-02.

What conditions does trial NCT06428175 study?

This clinical trial studies the following conditions: Pediatrics, Health Care, Transitional Care, Comparative Effectiveness, Family Engagement.

What interventions are being tested in trial NCT06428175?

The interventions under investigation include: Focused Dose Hospital-to-Home Transitional Care Interventions (BEHAVIORAL), Extended Dose Hospital-to-Home Transitional Care Interventions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06428175?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06428175 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatrics

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06428175's enrollment target sits among peer trials

480 3rd of 15 higher than 13 of 15 other Pediatrics trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pediatrics trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

  • NCT04948060 · 480 participants · NA

    Tribally Engaged Approaches to Lung Screening (TEALS)

  • NCT05053230 · 480 participants · NA

    A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06428175, the US trial registry maintained by the National Library of Medicine. NCT06428175 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.